Successfully reported this slideshow.
Your SlideShare is downloading. ×

OS16 - 6.G5.d Do Commercially Available Lysis Buffers Inactivate FMD Virus? - B. Wood

Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad

Check these out next

1 of 4 Ad
Advertisement

More Related Content

More from EuFMD (20)

Recently uploaded (20)

Advertisement

OS16 - 6.G5.d Do Commercially Available Lysis Buffers Inactivate FMD Virus? - B. Wood

  1. 1. www.pirbright.ac.ukThe Pirbright Institute receives strategic funding from BBSRC. Do commercially available lysis buffers inactivate foot-and-mouth disease virus? Britta Wood, Valérie Mioulet, Lissie Henry, Barsha Thapa, Ashley Gray, Don King
  2. 2. Given strict biosafety concerns and regulations for FMDV: •  Critical that lysis buffers used effectively inactivate •  Important for: -  Location of nucleic acid extraction experiments -  External transfer/shipment of samples Biosafety concern Purpose: Determine whether commercially available lysis buffers are able to lyse/inactivate FMDV effectively, as indicated by the lack of cytopathic effect (CPE)/virus replication in cell culture.
  3. 3. Lysis buffers: MagMAX lysis binding solution (Ambion, Life Tech) MagVet NM1 lysis buffer (LSI, Life Tech) RNeasy RLT buffer (Qiagen) Viruses: All seven serotypes Cell culture & original suspension 6.9-8.5 log TCID50/mL Cells: Primary bovine thyroid (BTY) Continuous pig (IB-RS-2) Experimental design Neg control CPE
  4. 4. Results to-date Lysis buffers inactivate FMDV in cell culture supernatants and original tissue suspensions. Future work will be conducted for: •  SVDV •  Different sample types

×